tiprankstipranks
Trending News
More News >
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market

Hansoh Pharmaceutical Group Company Limited (3692) Ratios

Compare
4 Followers

Hansoh Pharmaceutical Group Company Limited Ratios

HK:3692's free cash flow for Q4 2024 was ¥0.91. For the 2024 fiscal year, HK:3692's free cash flow was decreased by ¥ and operating cash flow was ¥0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.80 4.21 9.86 7.67 6.43
Quick Ratio
2.73 4.12 9.69 7.53 6.32
Cash Ratio
1.32 3.27 6.72 4.86 1.59
Solvency Ratio
0.42 0.50 0.40 0.42 0.96
Operating Cash Flow Ratio
0.53 0.45 1.05 0.85 0.89
Short-Term Operating Cash Flow Coverage
0.00 0.74 0.00 0.00 0.00
Net Current Asset Value
¥ 10.92B¥ 21.64B¥ 18.48B¥ 16.05B¥ 14.37B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.13 0.15 0.14 <0.01
Debt-to-Equity Ratio
<0.01 0.17 0.19 0.19 <0.01
Debt-to-Capital Ratio
<0.01 0.14 0.16 0.16 <0.01
Long-Term Debt-to-Capital Ratio
0.00 <0.01 0.16 0.16 0.00
Financial Leverage Ratio
1.50 1.28 1.32 1.36 1.16
Debt Service Coverage Ratio
20.49K 0.87 44.15 47.27 1.50K
Interest Coverage Ratio
22.61K 42.58 44.85 53.40 1.69K
Debt to Market Cap
0.00 0.05 0.06 0.04 0.00
Interest Debt Per Share
<0.01 0.70 0.75 0.66 0.02
Net Debt to EBITDA
-2.78 -4.32 -4.52 -3.53 -1.40
Profitability Margins
Gross Profit Margin
91.51%89.80%90.73%91.24%90.76%
EBIT Margin
32.02%37.93%27.79%28.39%31.91%
EBITDA Margin
34.14%41.56%31.25%31.04%34.40%
Operating Profit Margin
32.02%28.10%27.79%28.39%31.91%
Pretax Profit Margin
34.56%37.27%31.43%33.22%35.65%
Net Profit Margin
29.45%32.44%27.54%27.31%29.56%
Continuous Operations Profit Margin
29.45%32.44%27.54%27.31%29.56%
Net Income Per EBT
85.20%87.03%87.63%82.21%82.91%
EBT Per EBIT
107.93%132.64%113.08%117.00%111.73%
Return on Assets (ROA)
13.06%9.92%8.61%9.99%12.36%
Return on Equity (ROE)
19.60%12.71%11.41%13.54%14.37%
Return on Capital Employed (ROCE)
20.85%10.85%9.52%11.69%15.32%
Return on Invested Capital (ROIC)
18.02%8.13%8.35%9.64%13.56%
Return on Tangible Assets
13.06%9.97%8.62%9.99%12.36%
Earnings Yield
2.02%3.66%3.33%2.96%1.38%
Efficiency Ratios
Receivables Turnover
3.87 3.14 2.62 2.70 2.78
Payables Turnover
3.82 6.29 3.91 3.50 6.46
Inventory Turnover
1.78 1.79 1.94 2.12 2.69
Fixed Asset Turnover
4.50 3.08 2.72 2.86 3.77
Asset Turnover
0.44 0.31 0.31 0.37 0.42
Working Capital Turnover Ratio
1.27 0.45 0.43 0.57 0.67
Cash Conversion Cycle
204.03 262.00 233.83 202.90 210.56
Days of Sales Outstanding
94.41 116.11 139.21 135.05 131.36
Days of Inventory Outstanding
205.06 203.87 187.87 171.99 135.72
Days of Payables Outstanding
95.44 57.98 93.24 104.14 56.51
Operating Cycle
299.47 319.98 327.08 307.04 267.07
Cash Flow Ratios
Operating Cash Flow Per Share
0.61 0.50 0.46 0.44 0.41
Free Cash Flow Per Share
0.50 0.46 0.42 0.36 0.16
CapEx Per Share
0.11 0.04 0.05 0.08 0.24
Free Cash Flow to Operating Cash Flow
0.82 0.93 0.90 0.82 0.40
Dividend Paid and CapEx Coverage Ratio
1.59 3.58 2.78 3.06 0.42
Capital Expenditure Coverage Ratio
5.62 14.19 10.05 5.60 1.67
Operating Cash Flow Coverage Ratio
352.87 0.72 0.63 0.67 25.77
Operating Cash Flow to Sales Ratio
0.38 0.31 0.29 0.26 0.28
Free Cash Flow Yield
2.16%3.23%3.18%2.31%0.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
49.57 27.33 30.00 33.77 72.36
Price-to-Sales (P/S) Ratio
14.60 8.86 8.26 9.22 21.39
Price-to-Book (P/B) Ratio
9.72 3.47 3.42 4.57 10.40
Price-to-Free Cash Flow (P/FCF) Ratio
46.30 30.92 31.40 43.28 193.06
Price-to-Operating Cash Flow Ratio
38.06 28.74 28.28 35.55 77.76
Price-to-Earnings Growth (PEG) Ratio
1.17 2.00 -6.90 7.43 -11.34
Price-to-Fair Value
9.72 3.47 3.42 4.57 10.40
Enterprise Value Multiple
39.98 17.01 21.93 26.18 60.78
Enterprise Value
118.50B 71.43B 64.28B 80.75B 181.69B
EV to EBITDA
39.98 17.01 21.93 26.18 60.78
EV to Sales
13.65 7.07 6.85 8.13 20.91
EV to Free Cash Flow
43.29 24.66 26.04 38.14 188.70
EV to Operating Cash Flow
35.59 22.92 23.45 31.33 76.01
Tangible Book Value Per Share
2.38 4.08 3.82 3.38 3.04
Shareholders’ Equity Per Share
2.38 4.11 3.83 3.38 3.04
Tax and Other Ratios
Effective Tax Rate
0.15 0.13 0.12 0.18 0.17
Revenue Per Share
1.59 1.61 1.59 1.68 1.48
Net Income Per Share
0.47 0.52 0.44 0.46 0.44
Tax Burden
0.85 0.87 0.88 0.82 0.83
Interest Burden
1.08 0.98 1.13 1.17 1.12
Research & Development to Revenue
0.13 0.21 0.18 0.18 0.14
SG&A to Revenue
0.09 0.07 0.06 0.09 0.09
Stock-Based Compensation to Revenue
0.00 0.02 0.02 <0.01 <0.01
Income Quality
1.30 0.95 1.06 0.95 0.93
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis